Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma | |
Peng, Qiu-Xia; Han, Yun-Wei; Zhang, Yan-Ling; Hu, Jie; Fan, Juan; Fu, Shao-Zhi; Xu, Shan; Wan, Qiang | |
刊名 | ONCOTARGET |
2017 | |
卷号 | 8期号:32页码:52813-52822 |
关键词 | nasopharyngeal carcinoma apatinib VEGFR-2 cisplatin combined therapy |
DOI | 10.18632/oncotarget.17264 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4592656 |
专题 | 山东大学 |
作者单位 | Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou 646 |
推荐引用方式 GB/T 7714 | Peng, Qiu-Xia,Han, Yun-Wei,Zhang, Yan-Ling,et al. Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma[J]. ONCOTARGET,2017,8(32):52813-52822. |
APA | Peng, Qiu-Xia.,Han, Yun-Wei.,Zhang, Yan-Ling.,Hu, Jie.,Fan, Juan.,...&Wan, Qiang.(2017).Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma.ONCOTARGET,8(32),52813-52822. |
MLA | Peng, Qiu-Xia,et al."Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma".ONCOTARGET 8.32(2017):52813-52822. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论